CXCR5 and COVID-19: Regarding T cell immunity, the non‐hospitalized COVID-19 cases had higher CXCR5+ CD4+ T follicular helper cell responses than hospitalized cases, and virus‐specific CD4+ T cell responses correlated positively with serum anti-N and anti-S antibody levels within 180 days post-onset39.